Navigation Links
Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

a experienced a 20 percent tumor reduction. Lastly, a patient with NK/T cell lymphoma had a 75 percent reduction in tumor measurements. Adverse events included two Grade 3 dose- limiting toxicities (upper respiratory infection (URI) and elevated liver enzymes) and five cases of Grade 3 thrombocytopenia (low-platelet count) without any sign of bleeding.

Reductions in platelet counts were analyzed in the three ongoing Phase I trials as a biomarker of Bcl-2 family protein inhibition. Subjects received doses ranging from 10 mg to 315 mg. The study data demonstrate that ABT-263 induces a transient decrease in circulating platelets via inhibition of Bcl- XL, without decreasing platelet production, confirming on-target activity. At 315 mg, researchers observed a 69 percent reduction in mean platelets from baseline values. Typically, platelet nadir occurred on days three to five with recovery during continued dosing. Tumor regression was observed in six patients, with three patients showing more than 50 percent tumor shrinkage. Adverse events included three dose-limiting toxicities, one Grade 3 URI at 160 mg, one Grade 3 alanine aminotransferase (ALT) elevation at 315 mg and one fatal respiratory failure at 10 mg. Updated information will be presented at the ASCO Annual Meeting.

ABT-869

Twenty-four patients from a completed Phase I trial (ABT-869), which studied three dose levels of ABT-869, were evaluated to compare two different measures of angiogenesis using functional imaging -- the distributed parameter (DP) model and the transfer constant (Ktrans) model. DP is a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) model that enables derivation of blood flow and capillary permeability-surface area product (PS). Tests indicated that time over threshold could be an important predictor of efficacy, and results demonstrated that an appropriate value for the plasma concentration threshold could be 0.08 ug/mL, with time above threshold value of
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Citi Investment Research Global Health Care Conference
2. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
4. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
5. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
6. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
7. Abbott Hosts Conference Call for First-Quarter Earnings
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
10. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
11. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015 The Rheumatology Nurses Society ... excellence in care and safe practice for patients with ... RNS that biologic infusions are administered in an infusion ... of a registered nurse (RN), as defined in their ... occur in patients receiving these medications during a first ...
(Date:3/3/2015)... March 03, 2015 Dr. ... president and chief clinical integration and network ... In this newly established role, Dr. Nochomovitz ... NewYork-Presbyterian Healthcare System physician enterprise, its integration ... and Weill Cornell Physicians. , Dr. Nochomovitz ...
(Date:3/3/2015)... Topical BioMedics, Inc., announces its March Pain ... on Tuesday, March 10th, 12pm – 1pm and 4pm to ... 24/7. , The Pain Management Workshops are ... March 10th workshop is “Opioid Addiction: An Over-Medicated Society.” ... represents 5% of the world’s population, yet consumers 99% of ...
(Date:3/3/2015)... Vancouver, BC (PRWEB) March 03, 2015 ... almost doubled since 1984 to about 15%. This increases ... years old. (Bushnik T, Cook JL, Yuzpe AA, et ... Reproduction 2012; 27: 738-46). Dr. Jason Hitkari, a reproductive ... Brown, a doctor of TCM and clinical director and ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Introducing ... Dental Labs is a recognized leader in Digital ... produces the best dental replicas, leaving no ... 3D digital scanning, dental professionals are able to ... 3D printers consistently deliver remarkable quality while reducing ...
Breaking Medicine News(10 mins):Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 3Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 4Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 2Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 3
... , ... named Capital Confirmation, Inc. its 2010 Best in Business winner for the 1 – 25 ... ... provider of secure audit confirmation services, was named “Best in Business” in the 1 – ...
... ... report assessing best pharmaceutical value-added programs and account managers among key managed care ... ... an ongoing market research project that provides strategic and tactical information to assist ...
... variations might reveal women most at risk, researchers say , ... expression of two common genes trigger cellular changes that can ... researchers adjusted the expression of the genes -- estrogen receptor ... they made in the rodents likely mimic natural variations of ...
... Hundreds ... HCG and how can it help us? , ... May 13, 2010 -- HCG, or human chorionic gonadotropin, is a natural hormone that is found in ... as energy for both the mom and her developing baby. , , , , ,Now, thanks ...
... Non surgical ... ... (GLI) announced a revolutionary hair replication solution recently at their Edina, Mn, office. They utilize ... available. It restores the permanent look of a full head of hair in one day ...
... ... of IT consulting, with many companies providing a variety of high tech services nationwide. ... to offer a spectrum of services to commercial, academic, and governmental IT organizations. , ... South Plainfield, N.J. May 12, 2010 ...
Cached Medicine News:Health News:Capital Confirmation Named Best In Business by Nashville Business Journal 2Health News:Capital Confirmation Named Best In Business by Nashville Business Journal 3Health News:HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings 2Health News:HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings 3Health News:Small Changes in Two Genes May Trigger Breast Cancer 2Health News:All About the HCG Drops Diet Program—What it is and Why it Works 2Health News:Good Look Ink Announces Revolutionary Hair Replication Solution 2Health News:Astir IT Solutions Inc. Acquires Inothink Solutions 2
(Date:3/3/2015)... , March 3, 2015  The packaging ... market. It not only provides containment and drug ... and proper delivery. As patent loss delivers more ... will steadily rise, in turn encouraging low-cost innovation ... further expected to drive the pharmaceutical packaging industry ...
(Date:3/3/2015)... , March 3, 2015 Actavis plc (NYSE: ... priced an offering of $21 billion aggregate principal amount ... registered public offering to be issued by its indirect ... of its other subsidiaries (the "Notes"), as follows: ... Rate Senior Notes* , $500,000,000 , Due ...
(Date:3/3/2015)... 2015  Vermillion, Inc. (NASDAQ: VRML ), a ... will present at the 27 th Annual ROTH Conference, ... Dana Point, California from March 8 to March ... Valerie Palmieri , will be presenting on Monday, March 9 ... Eric Schoen , the company,s Vice President of Finance and ...
Breaking Medicine Technology:Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 2Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 3Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Vermillion To Present at 27th Annual ROTH Conference on March 9 2
... 4, 2011 PAREXEL International Corporation (Nasdaq: PRXL ... Morgan Healthcare Conference in San Francisco.  Josef von Rickenbach, Chairman ... PAREXEL at 8:30 a.m. PT on Thursday, January 13, 2011. ... available through the "Investors" section of PAREXEL,s website ...
... LAKES, N.J., Jan. 3, 2011 Medco Health Solutions, Inc. ... Snow Jr., is scheduled to present at the following healthcare ... The Goldman Sachs Healthcare CEOs Unscripted conference taking place in ... January 6, 2011 at 8:45 a.m. ET; ...
Cached Medicine Technology:PAREXEL International to Present at J.P. Morgan Healthcare Conference 2Medco CEO to Present at Upcoming Healthcare Conferences 2
Bayonet forceps....
Hardy bayonet forceps with stops. Insulated....
Cushing bayonet forceps. Insulated....
Insulated Bipolar Forceps...
Medicine Products: